Haemochromatosis

Haemochromatosis is a condition where the body absorbs and stores too much iron. Over time, this excess iron builds up in organs like the liver, heart, and pancreas, where it can cause serious and sometimes irreversible damage.

The condition is most often linked to changes in the HFE gene, which affect how your body regulates iron absorption. If you inherit certain variants in this gene, you may be at higher risk of developing haemochromatosis.

One of the challenges with haemochromatosis is that it rarely shows symptoms early on. Most people feel healthy for years, and only later in life do issues such as fatigue, joint pain, diabetes, or liver problems begin to appear. By the time symptoms are obvious, the damage may already be significant.

That’s where genetic testing can make a huge difference. If haemochromatosis is identified early, before symptoms develop, simple treatments such as routine blood monitoring and regular donation (phlebotomy) can prevent iron from reaching harmful levels. With timely diagnosis, people at risk can avoid the serious complications of the condition and live long, healthy lives. Genetic insight gives you the power to act early, before haemochromatosis has the chance to act at all.

Clinicians are equipped with actionable information to create tailored treatment plans. These plans are based on a patient’s genetic profile, enabling more precise medication selection, lifestyle recommendations, and monitoring strategies

Requirements: Blood Sample or Transfer of Whole Genome Data

Sequencing Time: 30 days

Analysis Time: 24 hours